共 108 条
[1]
Mones JV(2019)Management of Thrombocytopenia in Cancer patients Cancer Treat Res 179 139-50
[2]
Soff G(2018)Platelet transfusion for patients with Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update J Clin Oncol 36 283-99
[3]
Schiffer CA(2022)Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies Haematologica 107 1243-63
[4]
Bohlke K(2019)Thrombopoietin receptor agonists: ten years later Haematologica 104 1112-23
[5]
Delaney M(2021)Thrombopoietin receptor agonists (TPO-RAs): drug class considerations for pharmacists Drugs 81 1285-305
[6]
Hume H(2015)Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study Cancer Med 4 16-26
[7]
Magdalinski AJ(2017)Eltrombopag for Thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study Int J Hematol 106 765-76
[8]
McCullough JJ(2019)Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia J Clin Oncol 37 2892-8
[9]
Omel JL(2022)Avatrombopag for chemotherapy-induced thrombocytopenia in patients with non-haematological malignancies: an international, randomised, double-blind, placebo-controlled, phase 3 trial Lancet Haematol 9 e179-89
[10]
Rainey JM(2015)The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations Ann Intern Med 162 777-84